Skip to main content
. 2024 Oct 3;15:8578. doi: 10.1038/s41467-024-52379-2

Fig. 3. The regulatory role of ALOX15/15-HETE in the setting of hepatic I/R injury.

Fig. 3

a The experimental schema for establishing the mouse I/R injury model. The mice were intravenously administered PD146176 (10 mg/kg) or 15-HETE (0.5 mg/kg). b The 15-HETE level in the livers of each group 6 h after reperfusion (n = 4, per group). c Serum ALT and AST levels for each group 6 h after reperfusion (n = 7, per group). d Representative H&E staining, ROS staining, TUNEL staining and MPO IHC staining of liver sections from each group and quantification assessment (n = 7, per group). I/R, ischemia/reperfusion, ALT alanine aminotransferase, AST aspartate aminotransferase, HE hematoxylin and eosin, ROS reactive oxygen species, DHE dihydroethidium, TUNEL Terminal deoxynucleotidyl transferase dUTP nick end labeling, MPO cytosolic myeloperoxidase. Two-tailed t-test. Statistic data are presented as the mean ± SD, error bars represent the means of at least three independent experiments. p values are shown on the graphs, p < 0.05 was considered statistically significant. Source data are provided as a Source Data file. Figure 3a created with BioRender. com released under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International license (https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en).